What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos

1

Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers

2

Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge

3

Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
Close

Why Doctors and AIDS Advocates Oppose the FDA's New HIV-Prevention Pill

July 21, 2012, 10:20 AM
Pills%20new%20ss

What's the Latest Development?

The FDA has approved the first pill ever designed to prevent HIV infection after a series of tests, performed mostly in Africa, suggested that daily doses greatly reduce the risk of transmitting the virus. Called Truvada, the pill performed especially well in a an East African trial: "It reduced the incidence of HIV by 75% in people with partners who had been infected. In an earlier trial in the United States, HIV incidence dropped by 44% in men who have sex with men." Now US health insurers must decide whether they will pay for the treatment, which costs about $10,000 for a year's supply. 

What's the Big Idea?

The drug's approval was not without significant controversy. While most members of the FDA panel voted to approve the drug, many researchers, doctors and patient advocates expressed worries over drug resistance. Trials have shown that if HIV is exposed to emtricitabine and tenofovir, the two drugs in Truvada, in the acute phase of infection, the virus can develop a resistance. "To mitigate these risks, the FDA requires that Truvada be prescribed only once an individual has tested negative for HIV." Doctors have also expressed concern over patient compliance. If the drug is not taken regularly (and physicians say in many cases it will not be), HIV is more likely to become resistant. 

Photo credit: Shutterstock.com

 

 

Why Doctors and AIDS Advoca...

Newsletter: Share: